| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.83B | 19.43B | 31.39B | 24.68B | 5.27B | 9.41B |
| Gross Profit | 17.99B | 10.70B | 11.87B | 19.67B | -419.99M | 1.58B |
| EBITDA | 8.10B | 8.89B | 8.17B | 6.45B | -1.52B | -287.02M |
| Net Income | 4.30B | 5.07B | 4.60B | 2.64B | -5.23B | -3.85B |
Balance Sheet | ||||||
| Total Assets | 30.86B | 29.67B | 30.60B | 29.18B | 31.21B | 28.44B |
| Cash, Cash Equivalents and Short-Term Investments | 5.52B | 4.40B | 5.32B | 4.23B | 6.71B | 3.11B |
| Total Debt | 21.82B | 19.17B | 23.15B | 24.30B | 32.92B | 24.15B |
| Total Liabilities | 28.90B | 26.43B | 30.08B | 30.51B | 35.21B | 27.24B |
| Stockholders Equity | 1.97B | 3.25B | 527.53M | -1.33B | -4.00B | 1.20B |
Cash Flow | ||||||
| Free Cash Flow | 5.97B | 7.17B | 5.52B | 7.91B | -2.41B | -977.32M |
| Operating Cash Flow | 7.73B | 8.74B | 6.72B | 8.27B | -2.11B | -449.61M |
| Investing Cash Flow | -1.84B | -1.64B | -1.52B | -124.64M | -1.32B | -518.49M |
| Financing Cash Flow | -4.82B | -8.09B | -5.66B | -10.62B | 7.04B | 1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$157.41B | 15.71 | 13.12% | 3.06% | 4.94% | 15.38% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$42.41B | 9.82 | 344.91% | 5.73% | 5.59% | -4.38% | |
61 Neutral | HK$29.79B | 19.06 | -11.87% | 5.92% | -4.41% | -31.45% | |
52 Neutral | HK$138.56B | 22.71 | 71.16% | 2.39% | -3.13% | -13.65% | |
45 Neutral | HK$9.53B | 5.80 | -35.39% | ― | 13.18% | 86.18% | |
40 Neutral | HK$15.13B | -39.90 | -3.15% | ― | 12.29% | 98.20% |